Physician profile
Brick E Alva
NPI 1720025380
$1,834.13
in general payments reported to CMS, 2019-2025
20 companies · $169 in 2025
The $169 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $414 · 2020: $203 · 2021: $178 · 2022: $118 · 2023: $386 · 2024: $367 · 2025: $169.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $922.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $921.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $393.75 | 2019-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $384.40 | 2019-2025 | Entyvio, Eohilia |
| Intercept Pharmaceuticals, INC. | $152.53 | 2023 | Ocaliva |
| Genzyme Corporation | $124.97 | 2025 | |
| Braintree Laboratories, INC. | $112.29 | 2019-2023 | Sutab, Suflave |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $102.97 | 2019-2022 | |
| Redhill Biopharma INC. | $92.61 | 2020-2022 | |
| Intuitive Surgical, INC. | $92.22 | 2023 | Da Vinci Surgical System |
| Janssen Biotech, INC. | $59.45 | 2020-2023 | Simponi, Simponi Aria, Remicade |
| Ferring Pharmaceuticals INC. | $55.16 | 2019-2023 | Rebyota |
| Evoke Pharma, INC. | $44.50 | 2022 | |
| Boston Scientific Corporation | $39.40 | 2023-2024 | Resolution 360 Clip, Lux-Dx Insertable Cardiac Monitor |
| Covidien Lp | $37.81 | 2020 | |
| Ethicon US, LLC | $37.80 | 2020 | |
| Enterra Medical, INC. | $24.55 | 2023 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nestle Healthcare Nutrition INC. | $19.38 | 2021 | |
| Ironwood Pharmaceuticals, INC | $17.99 | 2019 | |
| Abbvie INC. | $15.58 | 2019 | |
| Shire North American Group INC | $14.30 | 2019 | |
| Allergan, INC. | $12.47 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brick Alva listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.